NASDAQ:ATHA
Athira Pharma
- Stock
Last Close
4.01
06/11 21:17
Market Cap
126.10M
Beta: 2.82
Volume Today
51.22K
Avg: 246.55K
PE Ratio
−1.03
PFCF: −1.30
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -650K - | -1.82M 179.69% | -1.78M 2.01% | -613.50K 65.56% | |||
average payables | 271K - | 789.50K 191.33% | 862.50K 9.25% | 1.53M 77.86% | 1.25M 18.48% | ||
average receivables | 6.50K - | 653.50K 9,953.85% | 1.82M 178.19% | 1.78M 2.01% | 613.50K 65.56% | ||
book value per share | -2.41 - | -2.29 4.73% | 22.92 1,099.81% | 8.70 62.06% | 6.23 28.34% | 3.42 45.05% | |
capex per share | -0.19 - | -0.04 78.02% | -0.03 29.02% | -0.01 73.56% | |||
capex to depreciation | -9.24 - | -3.28 64.47% | -1.35 58.88% | -0.31 76.77% | |||
capex to operating cash flow | 0.10 - | 0.04 62.07% | 0.02 56.86% | 0.00 80.84% | |||
capex to revenue | |||||||
cash per share | 0.78 - | 0.24 69.31% | 15.43 6,357.95% | 6.87 55.46% | 5.31 22.75% | 3.88 26.97% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.15 - | 0.71 384.73% | 0.00 99.50% | 0.01 61.67% | 0.01 28.01% | 9.89 133,516.86% | |
debt to equity | -0.05 - | -0.08 62.36% | 0.00 104.63% | 0.01 64.01% | 0.01 35.91% | 12.17 149,703.49% | |
dividend yield | |||||||
earnings yield | -0.05 - | -0.03 33.66% | -0.05 42.33% | -0.11 148.60% | -0.73 545.46% | -1.27 74.59% | |
enterprise value | 103.26M - | 146.70M 42.07% | 350.24M 138.74% | 372.47M 6.35% | 25.56M 93.14% | 1.59M 93.79% | |
enterprise value over ebitda | -20.29 - | -30.92 52.38% | -18.76 39.35% | -6.75 64.02% | -0.32 95.20% | -12.58 3,781.52% | |
ev to operating cash flow | -23.03 - | -39.51 71.54% | -14.53 63.24% | -8.64 40.50% | -0.35 95.92% | -15.75 4,365.47% | |
ev to sales | |||||||
free cash flow per share | -0.72 - | -0.43 40.44% | -2.21 411.82% | -1.21 45.22% | -1.95 61.24% | -2.66 36.25% | |
free cash flow yield | -0.04 - | -0.03 40.44% | -0.06 155.68% | -0.09 43.98% | -0.62 562.75% | -1.09 77.74% | |
graham net net | -2.42 - | -2.31 4.83% | 15.02 750.92% | 6.59 56.10% | 4.71 28.60% | 3.09 34.43% | |
graham number | 6.68 - | 5.31 20.50% | 28.34 433.72% | 16.98 40.10% | 18.01 6.08% | 15.44 14.25% | |
income quality | 0.88 - | 0.72 18.20% | 1.21 67.96% | 0.79 34.98% | 0.76 3.56% | 0.86 13.00% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -556.56 - | -15.75 97.17% | -54.48 245.95% | -21.34K 39,069.92% | -4.28 99.98% | ||
interest debt per share | 0.12 - | 0.22 86.80% | 0.11 48.25% | 0.05 54.40% | 0.70 1,234.51% | 41.69 5,897.81% | |
inventory turnover | |||||||
invested capital | -0.05 - | -0.08 62.36% | 0.00 104.63% | 0.01 64.01% | 0.01 35.91% | 12.17 149,703.49% | |
market cap | 105.85M - | 147.21M 39.07% | 409.87M 178.43% | 481.08M 17.38% | 119.61M 75.14% | 92.39K 99.92% | |
net current asset value | -14.92M - | -19.75M 32.36% | 187.06M 1,047.02% | 249.88M 33.58% | 184.52M 26.16% | 124.67K 99.93% | |
net debt to ebitda | 0.51 - | 0.11 79.21% | 3.19 2,911.40% | 1.97 38.36% | 1.19 39.40% | -11.85 1,093.39% | |
net income per share | -0.82 - | -0.55 33.66% | -1.56 184.92% | -1.47 5.42% | -2.31 57.03% | -3.10 33.83% | |
operating cash flow per share | -0.72 - | -0.43 40.44% | -2.01 366.90% | -1.17 42.07% | -1.92 64.53% | -2.65 37.98% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -1.03 - | -2.15 107.89% | -0.07 96.90% | -0.16 145.71% | -0.34 106.40% | -0.73 117.24% | |
revenue per share | |||||||
roe | 0.34 - | 0.24 30.37% | -0.07 128.50% | -0.17 149.27% | -0.37 119.15% | -0.90 143.56% | |
roic | 0.35 - | 0.27 21.57% | -0.07 124.74% | -0.20 189.01% | -0.40 103.34% | -0.04 90.30% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -2.41 - | -2.29 4.73% | 22.92 1,099.81% | 8.70 62.06% | 6.23 28.34% | 3.42 45.05% | |
stock based compensation to revenue | |||||||
tangible asset value | -14.89M - | -19.72M 32.48% | 274.28M 1,490.67% | 321.08M 17.06% | 235.14M 26.77% | 130.19K 99.94% | |
tangible book value per share | -2.41 - | -2.29 4.73% | 22.92 1,099.81% | 8.70 62.06% | 6.23 28.34% | 3.42 45.05% | |
working capital | 4.33M - | 887K 79.49% | 187.93M 21,087.37% | 251.51M 33.83% | 186.10M 26.01% | 125.89K 99.93% |
All numbers in USD (except ratios and percentages)